共查询到20条相似文献,搜索用时 93 毫秒
1.
目前癌症已成为人类的主要死因之一,在国家层面上建立起综合性的癌症防治研究核心机构以指导癌症的防控工作意义重大.日本国家癌症中心成立于1962年,目前已发展为世界上先进的癌症防控机构.全文对日本国家癌症中心从成立背景、理念及组织机构等方面作一简介. 相似文献
2.
Weerawut InsamranSuleeporn Sangrajrang 《Asian Pacific journal of cancer prevention》2020,21(3):577-582
Since 2000 cancer has been the leading cause of death in Thailand. In response to this challenge, the National Cancer Institute of Thailand (NCI), in collaboration with other bodies, has developed and promoted the National Cancer Control Program (NCCP) to provide appropriate policies and practice for the prevention, early detection and treatment of cancer, with optimal supportive care. With plans strongly supported by the Ministry of Public Health, the NCCP envisages integration into the health care system in 6 strategic areas: (1) cancer informatics; (2) primary prevention; (3) early detection; (4) treatment; (5) palliative care; and (6) cancer control research. For this purpose 7 regional cancer hospitals have been established to aid the NCI in conducting the NCCP. Cancer registration is a high priority, with 31.2% of the population now covered by quality registries. In primary prevention, there is a focus on awareness, lifestyle improvement, anti-smoking and alcohol control programs, vaccination, and Opisthorchis viverrini (OV) control. Screening programs for cervical, breast and colorectal cancer are underway to increase early detection. Priority is being given to facilities for chemotherapy and radiotherapy, as well as palliative care. Cancer control research encompasses international cooperation and participation in training programs, especially for development of cancer registration and other aspects of cancer control programs in South-East Asia, not least as an IARC Collaborating Center. 相似文献
3.
Catalona WJ Bailey-Wilson JE Camp NJ Chanock SJ Cooney KA Easton DF Eeles RA FitzGerald LM Freedman ML Gudmundsson J Kittles RA Margulies EH McGuire BB Ostrander EA Rebbeck TR Stanford JL Thibodeau SN Witte JS Isaacs WB 《Cancer research》2011,71(10):3442-3446
Compelling evidence supports a genetic component to prostate cancer susceptibility and aggressiveness. Recent genome-wide association studies have identified more than 30 single-nucleotide polymorphisms associated with prostate cancer susceptibility. It remains unclear, however, whether such genetic variants are associated with disease aggressiveness--one of the most important questions in prostate cancer research today. To help clarify this and substantially expand research in the genetic determinants of prostate cancer aggressiveness, the first National Cancer Institute Prostate Cancer Genetics Workshop assembled researchers to develop plans for a large new research consortium and patient cohort. The workshop reviewed the prior work in this area and addressed the practical issues in planning future studies. With new DNA sequencing technology, the potential application of sequencing information to patient care is emerging. The workshop, therefore, included state-of-the-art presentations by experts on new genotyping technologies, including sequencing and associated bioinformatics issues, which are just beginning to be applied to cancer genetics. 相似文献
4.
Mary Anne Bright 《Journal of cancer education》2007,22(2):S2-S7
Through the National Cancer Act and its amendments (National Cancer Act, 1971; National Cancer Act Amendments, 1974), the U.S. Congress mandated that the National Cancer Institute (NCI)—the nation’s lead agency for cancer information and research—provides accurate, up-to-date information about cancer to all segment of the U.S. population. In 1975, the NCI established the Cancer Information Service (CIS), a premieer resource for providing cancer information and education to the nation. The CIS is designed to maximize reach to the public by responding to the cancer needs of clients through several communication technologies, including a telephone service, e-mail, and real-time instant messaging. By offering cancer information to the public through one-on-one interactions with CIS information specialists, the CIS is in a unique position to fill the gap that lies between the preferred, interpersonal source of the health care provider and the actual, impersonal Internet. Cancer Information Service can play an important role in providing health care practitioners, health departments, caregivers, and researchers with up-to-date and accurate information about cancer and clinical trials. Currently, 10% of CIS callers are health professionals. Referring patients to the CIS can augment health practitioners’ ability to convey important health information to patients. The CIS program uses NCI resources to educate clients on cancer prevention, early detection, treatment, and rehabilitation and smoking cessation in simple terms that they can understand. Additionally, the CIS works with organizations to develop educational programs and interventions to reach underserved populations. A unique component of this information and education program is its ability to contribute to the field of health communications research by collaborating in research studies throughout the U.S. Finally, since its inception in 1975, the CIS has assisted international organizations with starting a cancer information service and as such is seen as a “stem cell” from which many international CIS programs have derived. 相似文献
5.
UMEGAKI YOICHIRO; SAKUDO MOTOTAKE; AMARI HIROKO; IIDA KOYO 《Japanese journal of clinical oncology》1974,4(1):1-32
Results of radiotherapy in the National Cancer Center Hospitalduring 19621970 were analysed by using the National CancerCenter Radiotherapy Computer System which had been developedby the authors. More than a half of the total cancer cases treatedin the hospital were given some kind of radiotherapy. The overallfive-year survival rate of radiotherapy cases corrected witha life table method were 38.4% for total cases, 44.6% for radicallytreated cases and 14.6% for palliatively treated cases. Combinedtreatment by radiation and surgery showed better results suchas 48.3% for preoperative and 57.8% for postoperative radiotherapycases. The following factors were analysed in terms of the five-yearsurvival rate: age, sex, stage, histology and double-primarycancer. In general, female cases showed much better prognosis than thatof male cases. Five-year survival rate showed its peak at 3040years of age and was low at lower or higher ages. Inverse correlationshipsby age were observed between the incidence of cancer and thesurvival rate after treatment, and the value of correlationcoefficient was larger in males and smaller in females. The age dependency of incidence and prognosis of cancer stronglysuggested the important role of host resistance in the treatmentand prevention of cancer.
*Present address: National Institute of Radiological SciencesChiba
**Present address: Chiba Cancer Center Hospital hiba 相似文献
6.
Margaret M. Farrell Kelsy M. Gibson Angela Marler Leslie Given Aubrey Van Kirk Villalobos Candace Deaton Maynard Frank S. Bright Ginny Thompson Kirklin Truemenda C. Green Melanie Ruhe Julia Thorsness Stephanie Weiss 《Cancer causes & control : CCC》2018,29(12):1205-1220
This paper explores how, through its extensive network of partners, the Comprehensive Cancer Control National Partnership (National Partnership) has provided a robust array of trainings, learning institutes, webinars, workshops, mentorship programs, and direct technical assistance to comprehensive cancer control programs and coalitions over the past 20 years. Mapping these activities to specific cancer control competencies revealed that the efforts of the National Partnership adequately address the core competencies necessary for an effective workforce and have the potential to increase practitioner capacity to adopt and implement evidence-based cancer control programs. Ensuring the continued availability and uptake of these tools, trainings and partnerships could potentially address gaps and barriers in the public health workforce related to evidence-based practice. 相似文献
7.
Rebecca L. Siegel MPH Kimberly D. Miller MPH Ahmedin Jemal DVM PhD 《CA: a cancer journal for clinicians》2016,66(1):7-30
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009‐2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth‐19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2016;7–30. © 2015 American Cancer Society. 相似文献
8.
Rebecca L. Siegel MPH Kimberly D. Miller MPH Ahmedin Jemal DVM PhD 《CA: a cancer journal for clinicians》2015,65(1):5-29
Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015. During the most recent 5 years for which there are data (2007‐2011), delay‐adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women. The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%. However, the magnitude of the decline varied by state, and was generally lowest in the South (~15%) and highest in the Northeast (≥20%). For example, there were declines of 25% to 30% in Maryland, New Jersey, Massachusetts, New York, and Delaware, which collectively averted 29,000 cancer deaths in 2011 as a result of this progress. Further gains can be accelerated by applying existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2015;65:5–29. © 2015 American Cancer Society. 相似文献
9.
10.
Jeannette F. Korczak Davyd W. Chung Erica Rosemond Daniel D. Von Hoff Richard L. Haspel John W. Waterbor Shine Chang Amelie G. Ramirez Susan Perkins Jonathan Wiest Ming Lei 《Journal of cancer education》2017,32(1):3-10
Through the R25 Cancer Education Grants Program (CEGP), the National Cancer Institute (NCI) has been supporting the broad educational needs of the cancer research and cancer healthcare communities since 1974. NCI sponsored a workshop on September 13, 2016 in Bethesda, Maryland, with the objectives of sharing best practices in cancer education, communicating R25 CEGP programmatic information, and gathering ideas to strengthen the R25 CEGP to better meet the emerging needs in cancer education in the face of a rapidly changing landscape in cancer research and cancer care. With 53 leaders in cancer education in attendance, the workshop featured an overview of the R25 CEGP by NCI Program Staff, a showcase of several types of CEGP programs by current R25 grantees, and in-depth discussions on a broad range of questions critical for the continued success of the R25 CEGP. The workshop afforded an opportunity, for the first time, for cancer researchers and clinicians conducting different forms of cancer education activities to gather in one place as leaders of a community of increasing importance. The discussion resulted in a set of suggestions that will benefit the R25 CEGP and cancer education in general. There was a general consensus among the participants that bringing the cancer education community together is a significant achievement of the workshop that will have a long-lasting impact on cancer education. 相似文献
11.
Pattama PloysawangJinda RojanamatinSomjit PrapakornPaphawin JamsriParinda PangmuangKanda SeedaSuleeporn Sangrajrang 《Asian Pacific journal of cancer prevention》2021,22(1):25-30
Background: Cervical cancer is an important public health problem in Thailand. It was the most common cancer in Thai women with the incidence rate of 23.4 per 100,000 women in 1990. Objective: The aim of this study was to share the experiences and summary the outcome of cervical cancer screening program in Thailand. Methods: The Ministry of Public Health in cooperation with the National Health Security Office, launched the National Cervical Cancer Screening Program, covering 76 provinces nationwide under Universal Coverage Scheme in 2005. The screening method are Pap smear and Visual Inspection with Acetic acid (VIA) for women aged 30-60 and 35-45 respectively with a 5-year screening interval. Detecting cervical pre-cancerous lesions will follow by day care treatment such as cryotherapy, Loop Electrosurgical Excision Procedure, etc. Results: The first phase (2005-2009), was carried out on 3,124,855 women, the coverage reached 77.5%. For the second phase (2010-2014), 7,637,226 women were screened, reaching 53.9% coverage of target women. However, we have few data of follow up examination after abnormal screening. Therefore, we conducted new system to get more follow up data in 2019. Under the coordination of many related partners, 10,762,081 women have been screened during 2005-2014. The incidence rate declined to 11.7 per 100,000 women which is ranked as the third most common in women in 2014. Conclusion: This article briefly reviews the challenge of implementing an efficient cervical cancer screening in Thailand. In 2020, HPV testing has been introduced as a primary screening test for all Thai women attending public health sector instead of conventional Pap test. 相似文献
12.
《Clinical breast cancer》2022,22(7):e832-e841
PurposeThe French National Cancer Institute has developed, in partnership with the French National Authority for Health, breast cancer-specific Care Quality, and Safety Indicators (BC QIs). With regard to the most common form of cancer, our aim is to support local and national quality initiatives, to improve BC pathways and outcomes, reduce heterogeneity of practice and regional inequities. In this study, we measure the BC QIs available in the French National medico-administrative cancer database, the French Cancer Cohort, for 2018.Materials and MethodsBC QIs are developed according to the RAND method. QIs are based on good clinical practice and care pathway recommendations. QI computation should be automatable without any additional workload for data collection. They will be published annually for all stakeholders, and especially hospitals.ResultsFinally, ten feasible and pertinent QIs were selected. In France, BC care was found to be close to compliance with most QIs: proportion of patients undergoing biopsy prior to first treatment (94.5%), proportion of patients undergoing adjuvant radiotherapy after breast-conserving surgery for BC (94.5%), proportion of women undergoing radiotherapy within 12 weeks after surgery and without chemotherapy (86.2%), proportion of DCIS patients undergoing immediate breast reconstruction (54.3%) and proportion of women with NMIBC undergoing breast reintervention (14.4%). However, some are still far from their recommended rate. In particular, some QIs vary considerably from one region, or one patient, to another.ConclusionEach result needs to be analyzed locally to find care quality leverage. This will strengthen transparency actions aimed at the public. 相似文献
13.
Overview of the National Cancer Screening Programme and the Cancer Screening Status in Korea
下载免费PDF全文
![点击此处可从《Asian Pacific journal of cancer prevention》网站下载免费的PDF全文](/ch/ext_images/free.gif)
《Asian Pacific journal of cancer prevention》2011,12(3):725-730
Organised cancer screening in Korea began in 1999. Operating system has been stabilised, target populationhave expanded and participation rate has been increased throughout its ten years. Here we present an overviewof the organised cancer screening system in Korea and introduce the National Cancer Screening Programmeincluding results from 2002 to 2008. Furthermore, we present the results of the Korea National Cancer ScreeningSurvey, a survey that is representative of the population, from 2004 to 2009. Finally, we discuss our achievementsand the future challenges. 相似文献
14.
Two National Cancer Plans (2003–2007 and 2009–2013) have been launched in France to organise the healthcare offer in order to enhance quality and safety. The current Cancer Plan1 defines regulatory frameworks across the three major areas of cancer therapy: surgery, chemotherapy and radiotherapy. These regulatory frameworks are based on three pillars: transversal requirements for the quality of care; establishment of minimal thresholds for institutions and technical criteria that are required for each type of cancer surgery. Based on adherence to these requirements and following a process of continuous assessment, institutional accreditations (currently being allocated in 2010) will be given for a period of 5 years. 相似文献
15.
Mun JY Han MA Lee HY Jun JK Choi KS Park EC 《Asian Pacific journal of cancer prevention》2011,12(8):1961-1964
The National Cancer Screening Programme (NCSP) began in 1999. The purpose of this report is to evaluate the results of the NCSP for cervical cancer in 2008 and to present essential evidence associated with the cervical cancer screening programme in Korea. Screening results were obtained from the National Cancer Screening Information System. Participation rates and recall rates were calculated with 95% confidence intervals (CIs). The target population of the cervical cancer screening programme in 2008 was 4,701,167 Korean women aged 30 and over, 1,208,581 of whom underwent Papanicolaou (Pap) smear tests (25.7% participation rate). The recall rate was 0.41% (95% CI, 0.40 to 0.42). Although efforts to facilitate participation and to reduce disparities in cervical cancer screening among Korean women are needed, the results do provide support for evidence-based strategies for control of cervical cancer in Korea. 相似文献
16.
Cancer screening practices from National Health Interview Surveys: past,present, and future 总被引:8,自引:0,他引:8
Hiatt RA Klabunde C Breen N Swan J Ballard-Barbash R 《Journal of the National Cancer Institute》2002,94(24):1837-1846
The National Health Interview Survey (NHIS) has provided data about health behaviors at the national level since 1957. The 1987 and 1992 Cancer Control Supplements to the NHIS, along with other supplemental surveys administered intermittently on self-reported cancer-related behaviors, have contributed to important research and public health purposes. In this article, we reviewed 73 papers published between 1980 and 2001 that used NHIS data, including the first report from the 1998 NHIS, to examine what has been learned from past surveys. Our goal was to facilitate future analyses of recently released data on cancer screening practices from the Cancer Control Supplement to the 2000 NHIS, which is now known as the Cancer Control Module. We categorized the papers according to which of the following three study approaches they used: trends in screening rates, correlates of these rates with factors that may influence screening, and linkages or comparisons of NHIS data with other surveys or sources of information. We summarize knowledge gained in cancer screening for each of these three categories and identify areas that could benefit from more research. We highlight some of the new information available for the first time on the Cancer Control Module of the 2000 NHIS as fresh opportunities for cancer control research. Finally, we describe how the Cancer Control Supplements to the NHIS are integrated with the objectives of and developments in national cancer surveillance research that have emerged from federal planning efforts and collaborations with national partners in cancer surveillance in recent years. 相似文献
17.
Cancer statistics, 2002 总被引:98,自引:0,他引:98
Every year the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival, using National Cancer Institute (NCI) incidence and National Center for Health Statistics (NCHS) mortality data. Incidence and death rates are age adjusted to the 1970 US standard population. It is estimated that 1,284,900 new cases of cancer will be diagnosed and 555,500 people will die from cancer in the United States in the year 2002. From 1992 to 1998, cancer death rates declined in males and females, while cancer incidence rates decreased among males and increased slightly among females. Most notably, African-American men showed the largest decline for both incidence and mortality. Nevertheless, African Americans still carry the highest burden of cancer with later-stage cancer diagnosis and poorer survival compared with whites. Despite the continued decline in cancer death rates, the total number of recorded cancer deaths in the United States continues to increase slightly due to the aging and expanding population. 相似文献
18.
Rebecca Cowens‐Alvarado MPH Katherine Sharpe MA Mandi Pratt‐Chapman MA Anne Willis MA Ted Gansler MD MBA MPH Patricia A. Ganz MD Stephen B. Edge MD Mary S. McCabe RN MA Kevin Stein PhD 《CA: a cancer journal for clinicians》2013,63(3):147-150
The National Cancer Survivorship Resource Center (The Survivorship Center) began in 2010 as a collaboration between the American Cancer Society and the George Washington University Cancer Institute and was funded by the Centers for Disease Control and Prevention. The Survivorship Center aims to improve the overall health and quality of life of posttreatment cancer survivors. One key to addressing the needs of this ever‐growing population is to develop clinical follow‐up care guidelines that emphasize not only the importance of surveillance for cancer recurrence, but also address the assessment and management of the physical and psychosocial long‐term and late effects that may result from having cancer and undergoing cancer treatment as well as highlight the importance of healthy behaviors that can reduce the risk of cancer recurrence, second primary cancers, and other chronic diseases. Currently, The Survivorship Center is coordinating the work of experts in oncology, primary care, and other health care professions to develop follow‐up care guidelines for 10 priority cancer sites. CA Cancer J Clin 2013. © 2013 American Cancer Society. 相似文献
19.
Rebecca Siegel MPH Jiemin Ma PhD Zhaohui Zou MS Ahmedin Jemal DVM PhD 《CA: a cancer journal for clinicians》2014,64(1):9-29
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics. A total of 1,665,540 new cancer cases and 585,720 cancer deaths are projected to occur in the United States in 2014. During the most recent 5 years for which there are data (2006‐2010), delay‐adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.4% per year in women. The combined cancer death rate (deaths per 100,000 population) has been continuously declining for 2 decades, from a peak of 215.1 in 1991 to 171.8 in 2010. This 20% decline translates to the avoidance of approximately 1,340,400 cancer deaths (952,700 among men and 387,700 among women) during this time period. The magnitude of the decline in cancer death rates from 1991 to 2010 varies substantially by age, race, and sex, ranging from no decline among white women aged 80 years and older to a 55% decline among black men aged 40 years to 49 years. Notably, black men experienced the largest drop within every 10‐year age group. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2014;64:9–29. © 2014 American Cancer Society, Inc. 相似文献
20.
Cancer treatment and survivorship statistics, 2012 总被引:1,自引:0,他引:1
Siegel R DeSantis C Virgo K Stein K Mariotto A Smith T Cooper D Gansler T Lerro C Fedewa S Lin C Leach C Cannady RS Cho H Scoppa S Hachey M Kirch R Jemal A Ward E 《CA: a cancer journal for clinicians》2012,62(4):220-241
Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER-Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers. 相似文献